Uherské Hradiště: Po - Pá: viz Ordinační doba
Uherský Brod: Po - Út: viz Ordinační doba
Uherské Hradiště: +420 572 551 850 
Uherský Brod: +420 572 629 124 
Akreditované pracoviště Ministerstva zdravotnictví ČR

MUDr. Eva Dokoupilová - životopis

Vzdělání

1989 - 1997

Physician at Department of Internal Medicine – Hospital Uherske Hradiste, Czech Republic

1993

1st Degree, Internal Medicine, 1993, J.E.Purkyně University Brno, Czech Republic – Nr.: 80526-P

1997

2st Degree, Rheumatology, 1997, IPVZ Prague, Czech Republic, Nr.: 88571-P

1997 - 2003

Head of Rheumatology Department – Hospital Uherské Hradiště, Uherské Hradiště, Czech Republic

2003 - 2012

Head of Private Rheumatology Department, Havlíčkova 3, Uherské Hradiště, 68601, Czech Republic

Since 2012

Head of Private Rheumatology Clinic, Obchodní 1507, Uherské Hradiště, 68601, Czech Republic

Publikace

2006

Fojtík, Z., Řehák, Z., Šimíková, J., Kielkowská, I., Dokoupilová, E. Non-invasive imaging in the diagnosis of large vessel vasculitis. Scand. J. Rheumatol., 2006, vol. 35, supl. 121, p. 52.

Fojtík, Z., Řehák, Z., Šimíková, J., Kielkowská, I., Dokoupilová, E. Non-invasive imaging in the diagnosis and management on large vessel vasculitis. In 6 th Central European Congress of Rheumatology, Bled, May 4th-6th, 2006, poster no. 102. Zdravniški vestnik, 2006, vol. 75, suppl. 1, p.I-10.

2010

Distler, O., Eich, W., Dokoupilova, E., Dvorak, Z., Fleck, M., Gaubitz, M., Hechler, M., Jansen, J.P., Krause, A., Bendszus, M., Pache, L., Reiter, R., Müller-Ladner, U. Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis and Rheumatism. 2010, vol. 62, no. 1, p. 291–300.

Branco, J.C., Zachrisson, O., Perrot, S., Mainguy, Y.; Multinational Coordinator Study Group, Collaborators: Klanova, I., Polivka, J., Svoboda, P., Dokoupilova, E., Danneskiold-Samsoe, B., Hannonen, .P, Kouri, J.P., Lehtonen-Veromaa, M., Partinen, M., Auvinet, B., Baron, D., Cherin, P., Courtheoux, F., Delorme, C., Dumolard, A., Picard, P., Hatron, P.Y., Lanteri-Minet, M., Maugars, Y., Mejjad, O., Schalck, R., Rioult, B., Roussel, P., Serra, E., Viel, E., Mazieres, B., Ginies, P., Cantagrel, N., De Korwin, J.D., Ginesty, E., Nadstawek, J., Neeck, G., Späth, M., Alten, R., Bolten, W., Bianchi, G., Biasi, G., Bombardieri, S., Cazzola, M., Cimmino, M.A., Fantini, F., Punzi, L., Venditti, C., Trotta, F., Matucci Cerinic, M., Grassi, W., Ofjord, S., Knudsrod, O., Szczepanski, L., Targonska-Stepniak, B., Szechiński, J., Araujo, D., Figueiredo, G., Tavares, V., Paiva, T., Cruz, M., Bolosiu, H., Codreanu, C., Ionescu, R., Radulescu, F., Suta, M., Collado, A., Alegre, C., Rivera, J., Rodriguez de la Serna, A., Riestra, J.L., Vidal, J., De Teresa, L., Petersson, I., Bragee, B., Sörensen, J., Walker, D. A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia. The Journal of Rheumatology. 2010, vol. 37, no. 4, p. 851–859.

2011

Dokoupilova, E. Úspěch biologické léčby u revmatoidní artritidy. Medical Tribune. 2011, vol. 7, no. 8, 2 p.

2012

Durez, P., Genovese, C. G., Richards, H. B., Supronik, J., Dokoupilova, E., Aelion, J. A., Lee, S.-H., Codding, C. E., Kellner, H., Ikawa, T., Hugot, S., Ligozio, G. and Mpofu, S. Secukinumab Treatment Provides Sustained Response Over One Year in Patients with Rheumatoid Arthritis. Congress Rheumatology 2012.

Genovese, M. C., Durez, P., Richards, H. B., Supronik, J., Dokoupilova, E., Mazurov, V., Aelion, J. A., Lee, S.-H., Codding, C. E., Kellner, H., Ikawa, T., Hugot, S., Mpofu, S., FRCP. Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody in patients with rheumatoid arthritis: A phase II, dose-finding, double-blind, randomized, placebo-controlled study. Annals of the Rheumatic Diseases. 2012.

2014

Genovese MC, Durez P, Richards HB, Supronik J, Dokoupilova E., Aelion JA, Lee SH, Codding CE, Kellner H, Ikawa T, Hugot S, Ligozio G, Mpofu S. One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled study. J Rheumatol. 2014 Mar;41(3):414-21. doi: 10.3899/jrheum.130637. Epub 2014 Jan 15.